Edwin Bremer

4.0k total citations · 1 hit paper
89 papers, 3.1k citations indexed

About

Edwin Bremer is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Edwin Bremer has authored 89 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 38 papers in Oncology and 34 papers in Molecular Biology. Recurrent topics in Edwin Bremer's work include Immunotherapy and Immune Responses (24 papers), CAR-T cell therapy research (21 papers) and Immune Cell Function and Interaction (19 papers). Edwin Bremer is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), CAR-T cell therapy research (21 papers) and Immune Cell Function and Interaction (19 papers). Edwin Bremer collaborates with scholars based in Netherlands, Germany and United Kingdom. Edwin Bremer's co-authors include Wijnand Helfrich, Valerie R. Wiersma, Marco de Bruyn, Douwe F. Samplonius, Paul Eggleton, Ewa Cendrowicz, Tomasz P. Rygiel, Zuzanna Sas, Marek Michalak and Lou de Leij and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Edwin Bremer

87 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Macrophages in Cancer Development and Therapy

2021 229 citations Ewa Cendrowicz, Edwin Bremer et al. Cancers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edwin Bremer Netherlands	34	1.6k	1.5k	935	322	315	89	3.1k
Paulette Mhawech‐Fauceglia United States	35	1.6k 1.0×	1.9k 1.3×	2.0k 2.2×	273 0.8×	245 0.8×	126	5.0k
Wijnand Helfrich Netherlands	38	1.4k 0.9×	1.7k 1.1×	1.2k 1.3×	237 0.7×	998 3.2×	114	3.7k
Andrew Nguyen United States	19	1.2k 0.7×	972 0.7×	1.2k 1.3×	162 0.5×	258 0.8×	46	2.6k
Xing Huang China	29	838 0.5×	1.7k 1.1×	1.2k 1.2×	368 1.1×	133 0.4×	110	3.2k
Mitomu Kioi Japan	23	701 0.4×	1.5k 1.0×	909 1.0×	565 1.8×	173 0.5×	63	3.5k
Ian Spendlove United Kingdom	32	1.4k 0.9×	1.3k 0.9×	983 1.1×	640 2.0×	326 1.0×	74	3.3k
Sabina Sangaletti Italy	33	2.4k 1.5×	1.3k 0.9×	1.6k 1.7×	180 0.6×	107 0.3×	81	4.4k
Leon Su United States	30	1.7k 1.1×	1.0k 0.7×	1.2k 1.3×	150 0.5×	284 0.9×	47	2.9k
Monica Rodolfo Italy	33	1.8k 1.1×	2.1k 1.4×	1.4k 1.5×	172 0.5×	169 0.5×	89	4.0k

Countries citing papers authored by Edwin Bremer

Since Specialization

Citations

This map shows the geographic impact of Edwin Bremer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Bremer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Bremer more than expected).

Fields of papers citing papers by Edwin Bremer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin Bremer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Bremer. The network helps show where Edwin Bremer may publish in the future.

Co-authorship network of co-authors of Edwin Bremer

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin Bremer. A scholar is included among the top collaborators of Edwin Bremer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin Bremer. Edwin Bremer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bremer, Edwin, et al.. (2024). Antibody desolvation with sodium chloride and acetonitrile generates bioactive protein nanoparticles. PLoS ONE. 19(3). e0300416–e0300416. 3 indexed citations

Choukrani, Ghizlane, et al.. (2024). Design of Vaterite Nanoparticles for Controlled Delivery of Active Immunotherapeutic Proteins. Particle & Particle Systems Characterization. 41(7). 1 indexed citations

Wang, Lu, Yu‐Sheng Lin, Zhimeng Yao, et al.. (2024). Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases. Drug Resistance Updates. 76. 101118–101118. 5 indexed citations

Wald, Ori, et al.. (2023). The DNA damage response pathway regulates the expression of the immune checkpoint CD47. Communications Biology. 6(1). 245–245. 14 indexed citations

Wiersma, Valerie R., et al.. (2023). EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells. Frontiers in Immunology. 14. 1191866–1191866. 7 indexed citations

Li, Kai, Yusheng Lin, Yu Zhou, et al.. (2023). Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study. Gastroenterology. 165(4). 932–945.e9. 40 indexed citations

Li, Meifang, Shaozhong Li, De Zeng, et al.. (2023). Notch1 promotes resistance to cisplatin by up-regulating Ecto-5′-nucleotidase (CD73) in triple-negative breast cancer cells. Cell Death Discovery. 9(1). 204–204. 11 indexed citations

Lubbers, Joyce M., Nienke van Rooij, Arjan Kol, et al.. (2022). Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer. Cancers. 14(8). 1924–1924. 4 indexed citations

Huls, Gerwin, et al.. (2022). CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma. Biomedicines. 10(5). 1175–1175. 29 indexed citations

10.

Choukrani, Ghizlane, Emanuele Ammatuna, Toshiro Niki, et al.. (2021). Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity. Biomedicines. 10(1). 66–66. 14 indexed citations

11.

Wang, Shuhong, Yusheng Lin, Xiao Xiong, et al.. (2020). Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial. Clinical Cancer Research. 26(18). 4921–4932. 119 indexed citations

12.

He, Yuan, Ewa Cendrowicz, Rudolf S.N. Fehrmann, et al.. (2019). CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL. Cancer Immunology Research. 7(10). 1663–1671. 28 indexed citations

13.

Bruyn, Marco de, Valerie R. Wiersma, Maartje C.A. Wouters, et al.. (2015). CD20⁺T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer. OncoImmunology. 4(4). e999536–e999536. 25 indexed citations

14.

Wiersma, Valerie R., Marco de Bruyn, Ce Shi, et al.. (2015). C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity. mAbs. 7(2). 321–330. 23 indexed citations

15.

Holley, Janet E., Edwin Bremer, Alexandra C. Kendall, et al.. (2014). CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination. Multiple Sclerosis and Related Disorders. 3(5). 650–658. 56 indexed citations

16.

Gooden, Marloes J.M., Valerie R. Wiersma, Douwe F. Samplonius, et al.. (2013). Galectin-9 Activates and Expands Human T-Helper 1 Cells. PLoS ONE. 8(5). e65616–e65616. 49 indexed citations

17.

Kuijlen, Jos M.A., Edwin Bremer, J.J.A. Mooij, Wilfred F.A. den Dunnen, & Wijnand Helfrich. (2010). Review: On TRAIL for malignant glioma therapy?. Neuropathology and Applied Neurobiology. 36(3). 168–182. 56 indexed citations

18.

Bremer, Edwin, Marco de Bruyn, Douwe F. Samplonius, et al.. (2008). Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells. Journal of Molecular Medicine. 86(8). 909–924. 26 indexed citations

19.

Bremer, Edwin, et al.. (2006). Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends in Molecular Medicine. 12(8). 382–393. 101 indexed citations

20.

Bremer, Edwin, Jos M.A. Kuijlen, Douwe F. Samplonius, et al.. (2003). Target cell‐restricted and ‐enhanced apoptosis induction by a scFv:sTRAIL fusion protein with specificity for the pancarcinoma‐associated antigen EGP2. International Journal of Cancer. 109(2). 281–290. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact